한글목차

세계의 에피네프린 시장은 2025년에 32억 5,000만 달러로 추정되며, 2032년에는 71억 1,000만 달러에 달할 것으로 예측되며, 2025-2032년 연간 평균 성장률(CAGR)은 11.8%로 성장할 전망입니다.

도표. 에피네프린 시장 점유율(%), 2025년 지역별 시장 점유율(%)

에피네프린은 아드레날린으로도 알려져 있으며, 아나필락시스, 심장마비, 표재성 출혈 등 다양한 질환을 치료하는 데 사용되는 호르몬이자 의약품입니다. 주사제로는 혈관부종, 아나필락시스 등 알레르기 반응의 치료에 사용됩니다. 또한 운동 유발성 기관지 수축이 있는 사람이 천식 발작을 예방하기 위해 사용하기도 합니다. 천식과 같은 질병 증가는 에피네프린 자동주사기 수요를 증가시킬 수 있습니다. 에피네프린이 아나필락시스의 표준 치료제로 등장하면서 자동 주사기의 기술 발전과 함께 시장 성장을 가속할 수 있습니다.

시장 역학

세계 에피네프린 시장 성장의 원동력은 아나필락시스 및 알레르기 반응 발생 건수 증가, 투여 편의성을 향상시키는 자동 주사기 기술 발전, 응급의료 현장 수요 증가, 아나필락시스의 1차 치료제로서 에피네프린 자동 주사기 채택 확대 등의 요인으로 분석됩니다. 그러나 자동주사기 관련 높은 비용, 주사제 에피네프린 부족으로 인한 가격 상승, 대체 치료 옵션에 대한 선호 등이 시장 성장을 저해하는 요인으로 작용할 수 있습니다. 바이오시밀러 에피네프린의 출현과 신흥 국가 시장 개발은 예측 기간 중 시장 진출기업에게 성장 기회를 제공할 수 있습니다.

본 조사의 주요 특징

• 세계의 에피네프린(Epinephrine) 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 연평균 성장률(CAGR%)을 게재하고 있습니다.
• 또한 다양한 부문에 걸친 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 에피네프린 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 보입니다.
• 세계 에피네프린 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
• 세계 에피네프린 시장을 분석할 때 사용되는 다양한 전략 매트릭스를 통해 이해관계자들은 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 리포트 설명
  • 시장의 정의와 범위
• 개요
• COM(Coherent Opportunity Map)(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 규제 시나리오
• 인수와 제휴 시나리오
• 자금조달과 투자
• PEST 분석
• Porter의 산업 분석

제4장 세계의 에피네프린 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부 구상
• 시장에 대한 COVID-19의 영향

제5장 세계의 에피네프린 시장, 제품 유형별, 2020-2032년(10억 달러)

• 서론
• 자동 주사기
• 프리필드 시린지
• 앰플과 바이알

제6장 세계의 에피네프린 시장, 용도별, 2020-2032년(10억 달러)

• 서론
• 아나필락시스
• 심정지
• 표면 출혈
• 호흡기질환
• 기타

제7장 세계의 에피네프린 시장, 유통 채널별, 2020-2032년(10억 달러)

• 서론
• 병원 약국
• 소매 약국
• 온라인 약국

제8장 세계의 에피네프린 시장, 지역별, 2020-2032년(10억 달러)

• 서론
• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제9장 경쟁 구도

• 기업 개요
  • Pfizer
  • Harvest Pharmaceuticals
  • Grand Pharma
  • Lincoln Medical, Ltd.
  • Abbott Laboratories
  • Sanofi SA
  • Mylan, Inc.
  • ALK Abello A/S
  • Amedra Pharmaceuticals LLC
  • Impax
  • Emerade
  • Tianjin Jinyao Group
  • Sandoz Inc.
  • Bausch Health Companies Inc.
  • Emerade
  • Antares Pharma Inc.

제10장 애널리스트의 권장사항

• 운명의 수레바퀴
• COM(Coherent Opportunity Map)

제11장 참고 문헌과 조사 방법

• 참고 문헌
• 조사 방법

영문목차

Global Epinephrine Market is estimated to be valued at USD 3.25 Bn in 2025 and is expected to reach USD 7.11 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.8% from 2025 to 2032.

Figure. Epinephrine Market Share (%), By Region 2025

Epinephrine, also known as adrenaline, is a hormone and medication that is used to treat a number of medical conditions such as anaphylaxis, cardiac arrest, and superficial bleeding. As an injection, it is used to treat allergic reactions like angioedema or anaphylaxis. It may also be used by people with exercise-induced bronchoconstriction to prevent asthma attacks. Rising diseases like asthma can boost demand for epinephrine auto-injectors. Emergence of epinephrine as the standard treatment for anaphylaxis along with technological advancements in autoinjectors can drive the market growth.

Market Dynamics:

Global epinephrine market growth is driven by factors such as rising incidences of anaphylaxis and allergic reactions, technological advancements in auto-injectors improving ease of administration, increasing demand from emergency medical settings, and growing adoption of epinephrine auto-injectors as the first line treatment for anaphylaxis. However, factors such as high costs associated with auto-injectors, shortage of injectable epinephrine exacerbating prices, and preference for alternative therapeutic options can hamper the market growth. Emergence of biosimilar epinephrine and expansion into developing regions can offer growth opportunities for market players during the forecast period.

Key Features of the Study:

• This report provides in-depth analysis of the global epinephrine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global epinephrine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Mylan N.V., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Impax Laboratories, LLC, Kaleo, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global epinephrine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global epinephrine market.

Detailed Segmentation-

• By Product Type
  • Auto-injector
  • Prefilled Syringes
  • Ampoules and Vials
• By Application
  • Anaphylaxis
  • Cardiac Arrest
  • Superficial Bleeding
  • Respiratory Disorders
  • Others
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Pfizer
  • Harvest Pharmaceuticals
  • Grand Pharma
  • Lincoln Medical, Ltd.
  • Abbott Laboratories
  • Sanofi S.A.
  • Mylan, Inc.
  • ALK Abello A/S
  • Amedra Pharmaceuticals LLC
  • Impax
  • Emerade
  • Tianjin Jinyao Group
  • Sandoz Inc.
  • Bausch Health Companies Inc.
  • Antares Pharma Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Application
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Epinephrine Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Epinephrine Market, By Product Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Auto-injector
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Prefilled Syringes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ampoules and Vials
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Epinephrine Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Anaphylaxis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiac Arrest
  • Mammography
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Superficial Bleeding
  • Chest X-ray
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Respiratory Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Epinephrine Market, By Distribution Channel, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Epinephrine Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Pfizer
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Harvest Pharmaceuticals
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Grand Pharma
  • Lincoln Medical, Ltd.
  • Abbott Laboratories
  • Sanofi S.A.
  • Mylan, Inc.
  • ALK Abello A/S
  • Amedra Pharmaceuticals LLC
  • Impax
  • Emerade
  • Tianjin Jinyao Group
  • Sandoz Inc.
  • Bausch Health Companies Inc.
  • Emerade
  • Antares Pharma Inc.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact